News Release
Wednesday, December 9, 2020
Postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to a limited number of lymph nodes, and whose recurrence risk is relatively low, do not benefit from chemotherapy when it is added to hormone therapy, according to initial results from a clinical trial presented at the 2020 San Antonio Breast Cancer Symposium. These findings may save tens of thousands of postmenopausal women each year the time, money, and harmful side effects that come with chemotherapy infusions.
This is the first evidence in a randomized phase III trial that postmenopausal women with HR-positive, HER2-negative breast cancer that has spread to one to three lymph nodes can safely forgo chemotherapy if their recurrence score on a genomic tumor tissue test is 25 or less. The trial also demonstrated, after a median of five years of follow-up, that premenopausal women with the same disease characteristics benefited from chemotherapy.
The study, SWOG S1007, known as RxPONDER, was supported by the National Cancer Institute (NCI), part of the National Institutes of Health; designed and led by SWOG Cancer Research Network; and conducted by the NCI National Clinical Trials Network. RxPONDER was an international effort, conducted at 632 sites in nine countries the United States, Canada, Mexico, Colombia, Ireland, France, Spain, Korea, and Saudi Arabia.
Every day in clinics around the world, physicians wrestle with the question of how to best treat women with this common form of breast cancer, said study lead author Kevin Kalinsky, M.D., a long-time SWOG investigator and director of the Glenn Family Breast Center at the Winship Cancer Institute of Emory University, Atlanta. These results are practice-changing and demonstrate that postmenopausal women can be spared unnecessary chemotherapy and receive only hormone therapy. This should bring more clarity to physicians and some relief for patients.
RxPONDER follows the ground-breaking TAILORx study, which was also supported by NCI. TAILORx showed that postmenopausal women with lymph node-negative, HR-positive, HER2-negative breast cancer and recurrence scores of 25 or less on a genomic tumor tissue test saw no benefit from the addition of chemotherapy to hormone therapy compared with hormone therapy alone. These results, however, left open the question of the most effective way to treat women diagnosed with more advanced breast cancer that has spread to the lymph nodes.
Analyses of data from stored tumor samples of patients in an earlier SWOG clinical trial, S8814, had suggested that recurrence scores from patients with lymph node-positive breast cancer that is HR positive and HER2 negative could potentially predict chemotherapy benefit. The study team set out to find out if this was true, using a molecular test called the Oncotype DX Breast Recurrence Score. This test, also used in TAILORx, assesses the activity of 21 genes to generate a score that indicates the risk of recurrence. Scores range from 0 to 100, with 25 and below rated in the low or intermediate risk range.
The RxPONDER team screened 9,383 women with HR-positive, HER2-negative breast cancer and one to three positive lymph nodes to identify those with recurrence scores of 25 or less. A total of 5,083 such patients were randomly assigned to receive hormone therapy alone or hormone therapy plus several months of intravenous chemotherapy with taxane and/or anthracyclines, chemotherapy drugs that are considered standard treatment for this type of cancer. Two-thirds of the women in the trial were postmenopausal, and data from 5,015eligiblerandomized patients were used in the current analysis.
All women were monitored for a median of five years to assess the trials primary endpoint, invasive disease-free survival, or IDFS, a measure that counts which patients develop cancer that spreads outside of the breast, develop a new tumor inside a breast, or die from any cause. Overall survival was a secondary endpoint. As an independent data and safety monitoring committee began reviewing the trial results, they noticed a surprising pattern one that was clear enough for the committee to recommend that findings be reported publicly before the final results were complete. When NCI received the committees recommendation, they agreed.
The researchers were surprised to find that in the study population overall, there was no association between recurrence score and chemotherapy benefit. In other words, patients with a higher recurrence score did not have a greater benefit from chemotherapy than those with a lower score. However, there was an association with menopausal status. Postmenopausal women saw no benefit from chemotherapy, regardless of recurrence score. Among postmenopausal women, the five-year IDFS rate was 91.6% for the chemotherapy plus hormone therapy group and 91.9% for the hormone therapy-only group.
By contrast, among premenopausal women, the study found a statistically significant benefit from chemotherapy in IDFS: The five-year IDFS rate in premenopausal women was 94.2% for the chemotherapy and hormone therapy group, compared with 89.0% for the hormone therapy-only group. This benefit was seen regardless of recurrence score. Premenopausal women also appeared to experience an overall survival benefit in these early results. At five years, the overall survival rate was 98.6% for those receiving chemotherapy plus hormone therapy and 97.3% for women in the hormone therapy-only group.
This study represents an important step toward the goal of matching patients with the most appropriate therapies and ensuring that patients do not receive treatments that are unlikely to benefit them, said Larissa Korde, M.D., M.P.H., head of Breast Cancer and Melanoma Therapeutics in NCIs Cancer Therapy Evaluation Program. These findings and additional results from this clinical trial can be expected to help improve the care of many women with a common form of breast cancer.
RxPONDER will follow patients for 15 years, so additional data and insights are to come. One unknown is why premenopausal women in the study benefited from chemotherapy while postmenopausal women did not. One possible explanation is that chemotherapy can induce menopause, starving the cancer of the hormones it needs to grow. Additional research is needed to explore whether treatment with medications that induce menopause given in combination with standard hormone therapy would have the same effect on risk of recurrence as that seen with chemotherapy in this study.
RxPONDER was funded by NCI, the Susan G. Komen for the Cure Research Program, The Hope Foundation for Cancer Research, Breast Cancer Research Foundation, and Exact Sciences.
About the National Cancer Institute (NCI):NCI leads the National Cancer Program and NIH's efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI website at cancer.gov or call NCIs contact center, the Cancer Information Service, at 1-800-4-CANCER (1-800-422-6237).
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIHTurning Discovery Into Health
###
Go here to see the original:
Some postmenopausal women with common breast cancer may forgo chemotherapy - National Institutes of Health
- HGH Infrared Systems Announces Debut of Spynel-S and Product Name Change - April 29th, 2013 [April 29th, 2013]
- Report: Biogenesis documents link A-Rod to HGH - April 29th, 2013 [April 29th, 2013]
- HGH Infrared Systems Announces New Blackbody Products and Updates - April 29th, 2013 [April 29th, 2013]
- "Anti-Aging" Pill SeroVital™-hgh Gets Overwhelming Response in The New York Times Magazine - April 29th, 2013 [April 29th, 2013]
- Radar Online Features Celebrity Makeup Artist's Anti-Aging Secret... SeroVital™-hgh - April 29th, 2013 [April 29th, 2013]
- De Smith says players will not be 'bullied' on HGH testing - April 29th, 2013 [April 29th, 2013]
- Smith says players won't be bullied on HGH test - April 29th, 2013 [April 29th, 2013]
- BraceLand Nutraceuticals - Turn Back Time with HGH - Video - April 29th, 2013 [April 29th, 2013]
- WWE '13 - HGH Clan vs spideysams - Video - April 29th, 2013 [April 29th, 2013]
- 216 Owner - April 29th, 2013 [April 29th, 2013]
- WvW HGH roaming aggressive conditions engineer (100'nades sequel) - Video - April 29th, 2013 [April 29th, 2013]
- WWE"13 WWE"13 xVBIx Pride Owned HGH zBrahmaBullz / My Epic Return - Video - April 29th, 2013 [April 29th, 2013]
- WWE '13 - HGH Clan vs P8909362, MrX206 and Danfort91 - Video - April 29th, 2013 [April 29th, 2013]
- Dr. Ed Park on why TA-65 is better than HGH - iHealthTube 8 - Video - April 29th, 2013 [April 29th, 2013]
- 15 mins HGH (Human Growth Hormone) release with Delta Isochronic - April 29th, 2013 [April 29th, 2013]
- Report: NFL HGH use likely common - May 1st, 2013 [May 1st, 2013]
- Anonymous player: HGH use in NFL 'like clockwork' - May 1st, 2013 [May 1st, 2013]
- HGH in the NFL: A growing menace - May 1st, 2013 [May 1st, 2013]
- HGH use in the NFL, still apparently subject for debate - May 1st, 2013 [May 1st, 2013]
- HGH use 'rampant' in NFL, according to report - May 1st, 2013 [May 1st, 2013]
- Report: HGH Use in NFL Is ‘Rampant,’ ‘Increasing’ With No Blood Test in Place - May 1st, 2013 [May 1st, 2013]
- Report: HGH use increasing - May 1st, 2013 [May 1st, 2013]
- PFT: HGH use reportedly rampant across league - May 3rd, 2013 [May 3rd, 2013]
- WWE '13 - HGH Clan OWNING these T-Rashy ass SPAMMERS - Video - May 3rd, 2013 [May 3rd, 2013]
- League wants HGH testing, needs players to want it, too - May 4th, 2013 [May 4th, 2013]
- WWE '13 - HGH KILLS Vendetta and NK CoLdR - Video - May 6th, 2013 [May 6th, 2013]
- Start Up Suplementos (360°) RENEWAL HGH Workout for Men 30ml Always Young - Video - May 6th, 2013 [May 6th, 2013]
- "Fountain of Youth" Pill SeroVital™-hgh Huge Draw at Annual Gynecology Meeting - May 8th, 2013 [May 8th, 2013]
- hGH Rap (Thrift Shop Parody) - Video - May 8th, 2013 [May 8th, 2013]
- WWE '13 - HGH vs KSA - Video - May 9th, 2013 [May 9th, 2013]
- WWE '13 - HGH Clan vs ObeyCrisz - May 9th, 2013 [May 9th, 2013]
- WWE '13 - HGH Clan vs jaTT253 - May 9th, 2013 [May 9th, 2013]
- WWE '13 - HGH vs The Shield? - Video - May 9th, 2013 [May 9th, 2013]
- WWE '13 - HGH Clan vs The1337Rasengan, Vinodhstanley and Chevyochenta - Video - May 9th, 2013 [May 9th, 2013]
- WWE '13 - HGH Clan OWNS Misfits_Owner, E214Classic and Kieron_Reynolds - Video - May 9th, 2013 [May 9th, 2013]
- WWE '13 - HGH Clan vs bigjoker____, FINAL7ROMANRAT, and VENdeTTA_RIppER - Video - May 11th, 2013 [May 11th, 2013]
- WWE '13 - HGH Clan vs PROOF_WANTED, OcaSs013_NDS and VigilanteWave24 - Video - May 11th, 2013 [May 11th, 2013]
- AhmetKayaGiderim-HGH-vidimob - Video - May 12th, 2013 [May 12th, 2013]
- J-rich94 - May 12th, 2013 [May 12th, 2013]
- WWE '13 - HGH Clan OWNS LordRaiku123 (NK Clan Member) - Video - May 17th, 2013 [May 17th, 2013]
- Footloose - Act One - Scene 4 - A Hgh School Hallway - Video - May 17th, 2013 [May 17th, 2013]
- Genuine HGH Available and AAS - Video - May 18th, 2013 [May 18th, 2013]
- Vlog Diaxu i HGH odc.2 - Video - May 18th, 2013 [May 18th, 2013]
- HGH Hormone Release + 528 Hz Virtual Anti Aging Spa Fatburner Mood Enhancer - Video - May 18th, 2013 [May 18th, 2013]
- WWE '13 - HGH vs 216 - Oh_216_Punk (Owner) and Oh_216_Prophecy - 'Bow Down/I Been On' by Beyonce - Video - May 18th, 2013 [May 18th, 2013]
- HGH Energizer Review By AgeExperts.net - Video - May 20th, 2013 [May 20th, 2013]
- Take me to the king Hgh's flag and banner - Video - May 20th, 2013 [May 20th, 2013]
- Best HGH Supplement - Video - May 21st, 2013 [May 21st, 2013]
- Testosterone - May 22nd, 2013 [May 22nd, 2013]
- Lack of HGH testing leaves hole in drug program - May 23rd, 2013 [May 23rd, 2013]
- Mark Sisson Primal Diet review HGH - May 23rd, 2013 [May 23rd, 2013]
- Humovox HGH Reviews - Supplementing.com - Video - May 23rd, 2013 [May 23rd, 2013]
- Bruce ( Spit ) Kimble - May 24th, 2013 [May 24th, 2013]
- NFL roundup: NFL proposes immediate HGH testing - May 25th, 2013 [May 25th, 2013]
- Report: NFL makes proposal for HGH testing - May 25th, 2013 [May 25th, 2013]
- NFL submitted proposal for immediate HGH testing, according to report - May 25th, 2013 [May 25th, 2013]
- IM A BOSS IN HGH - Video - May 26th, 2013 [May 26th, 2013]
- WWE '13 - HGH vs SMK-Ace_SkillZ (SMK Clan) WEAK BITCHES! - Video - May 28th, 2013 [May 28th, 2013]
- Invigorate HGH Reviews - Supplementing.com - Video - May 28th, 2013 [May 28th, 2013]
- Tarair Returned - 5v5 HGH Elixir Engineer - Video - May 28th, 2013 [May 28th, 2013]
- XxL3GACYxX-_ vs HGH Owner Kavan/BSS Owner Kavan - Video - May 29th, 2013 [May 29th, 2013]
- WWE '13 - HGH vs MOD - Video - May 29th, 2013 [May 29th, 2013]
- Discount Hgh Supplements - Promo Code - Video - May 30th, 2013 [May 30th, 2013]
- WWE '13 - HGH is STILL BETTER THAN NK - Video - May 30th, 2013 [May 30th, 2013]
- HGH Infrared Systems Presents to United 4 Defense, the Growing Cambridge-Based Defense-Technology Networking Group - May 31st, 2013 [May 31st, 2013]
- WWE'13 vs. HGH_LdR_LEVI HGH-Kavan-Owner HGH-Braham_Bullz - Video - May 31st, 2013 [May 31st, 2013]
- Exposing HGH - Video - May 31st, 2013 [May 31st, 2013]
- HGH 800 Hormona del Crecimiento - Video - May 31st, 2013 [May 31st, 2013]
- 2013 NBA Playoffs, Ducks Update, NFL HGH Testing, UFC 160 - May 31st, 2013 [May 31st, 2013]
- Hgh Code - Promo code Code - Video - June 1st, 2013 [June 1st, 2013]
- Hgh Coupon - Coupon Code - Video - June 1st, 2013 [June 1st, 2013]
- Discount Hgh - Coupon code Code - Video - June 3rd, 2013 [June 3rd, 2013]
- Hgh Discount - Discount Code - Video - June 3rd, 2013 [June 3rd, 2013]
- Official HGH Clan™ |Recruiting Videos| - Video - June 3rd, 2013 [June 3rd, 2013]
- Straight Dogged: HGH LDR Gets The Treatment - Video - June 4th, 2013 [June 4th, 2013]
- Increase HGH Naturally - Try RISK FREE - Hype or Real? - Video - June 4th, 2013 [June 4th, 2013]
- Growth Hormone Booster SeroVital®-hgh Causing Frenzy of Excitement at Renowned Sleep Conference - June 6th, 2013 [June 6th, 2013]
- Wwe13 vs HGH CLAN: HGH-Brahma_Bullz - June 6th, 2013 [June 6th, 2013]
- WWE '13 - HGH owns xSinFulxEniGmAx - June 6th, 2013 [June 6th, 2013]
- HGH Energizer Reviews - Video - June 6th, 2013 [June 6th, 2013]